Ocugen, Inc. — Director's Dealing 2024

Nov 15, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2024-11-14

Reporting Person: Ramachandran Ramesh (Chief Accounting Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1800	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (Right to Buy)	$1.25	2034-09-09	Common Stock (154596)		Direct

Footnotes

F1: The option vests annually in equal installments over three years commencing on September 9, 2025, subject to continued service with the Issuer on the applicable vesting dates.